@article{adler-moore.etal_2019,
  title = {Preclinical {{Safety}}, {{Tolerability}}, {{Pharmacokinetics}}, {{Pharmacodynamics}}, and {{Antifungal Activity}} of {{Liposomal Amphotericin B}}},
  author = {{Adler-Moore}, J. and Lewis, R.E. and Br{\"u}ggemann, R.J.M. and Rijnders, B.J.A. and Groll, A.H. and Walsh, T.J.},
  year = {2019},
  journal = {Clinical Infectious Diseases},
  volume = {68},
  pages = {S244-S259},
  doi = {10.1093/cid/ciz064},
  note = {Cited By :23
\par
Cited By :23
\par
Export Date: 20 November 2022
\par
Export Date: 20 November 2022},
  file = {/Users/russelllewis/Zotero/storage/6XRM4Q47/Adler-Moore et al_2019_Preclinical Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and.pdf}
}

{"_id":"MZZKJKGzY5EoWGt2m","bibbaseid":"adlermoore-lewis-brggemann-rijnders-groll-walsh-preclinicalsafetytolerabilitypharmacokineticspharmacodynamicsandantifungalactivityofliposomalamphotericinb-2019","author_short":["Adler-Moore, J.","Lewis, R.","Brüggemann, R.","Rijnders, B.","Groll, A.","Walsh, T."],"bibdata":{"bibtype":"article","type":"article","title":"Preclinical Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Antifungal Activity of Liposomal Amphotericin B","author":[{"propositions":[],"lastnames":["Adler-Moore"],"firstnames":["J."],"suffixes":[]},{"propositions":[],"lastnames":["Lewis"],"firstnames":["R.E."],"suffixes":[]},{"propositions":[],"lastnames":["Brüggemann"],"firstnames":["R.J.M."],"suffixes":[]},{"propositions":[],"lastnames":["Rijnders"],"firstnames":["B.J.A."],"suffixes":[]},{"propositions":[],"lastnames":["Groll"],"firstnames":["A.H."],"suffixes":[]},{"propositions":[],"lastnames":["Walsh"],"firstnames":["T.J."],"suffixes":[]}],"year":"2019","journal":"Clinical Infectious Diseases","volume":"68","pages":"S244-S259","doi":"10.1093/cid/ciz064","note":"Cited By :23 \\par Cited By :23 \\par Export Date: 20 November 2022 \\par Export Date: 20 November 2022","file":"/Users/russelllewis/Zotero/storage/6XRM4Q47/Adler-Moore et al_2019_Preclinical Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and.pdf","bibtex":"@article{adler-moore.etal_2019,\n title = {Preclinical {{Safety}}, {{Tolerability}}, {{Pharmacokinetics}}, {{Pharmacodynamics}}, and {{Antifungal Activity}} of {{Liposomal Amphotericin B}}},\n author = {{Adler-Moore}, J. and Lewis, R.E. and Br{\\\"u}ggemann, R.J.M. and Rijnders, B.J.A. and Groll, A.H. and Walsh, T.J.},\n year = {2019},\n journal = {Clinical Infectious Diseases},\n volume = {68},\n pages = {S244-S259},\n doi = {10.1093/cid/ciz064},\n note = {Cited By :23\n\\par\nCited By :23\n\\par\nExport Date: 20 November 2022\n\\par\nExport Date: 20 November 2022},\n file = {/Users/russelllewis/Zotero/storage/6XRM4Q47/Adler-Moore et al_2019_Preclinical Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and.pdf}\n}\n\n","author_short":["Adler-Moore, J.","Lewis, R.","Brüggemann, R.","Rijnders, B.","Groll, A.","Walsh, T."],"key":"adler-moore.etal_2019","id":"adler-moore.etal_2019","bibbaseid":"adlermoore-lewis-brggemann-rijnders-groll-walsh-preclinicalsafetytolerabilitypharmacokineticspharmacodynamicsandantifungalactivityofliposomalamphotericinb-2019","role":"author","urls":{},"metadata":{"authorlinks":{}}},"bibtype":"article","biburl":"https://bibbase.org/f/a6GBPjh3wXfA46RXX/CV.bib","dataSources":["qLqjc4bwMYLmk2F3c","8E62bsJiEchQrmW6z"],"keywords":[],"search_terms":["preclinical","safety","tolerability","pharmacokinetics","pharmacodynamics","antifungal","activity","liposomal","amphotericin","adler-moore","lewis","brüggemann","rijnders","groll","walsh"],"title":"Preclinical Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Antifungal Activity of Liposomal Amphotericin B","year":2019}